stock.name

Alnylam Pharmaceuticals Inc

ALNY

Market Cap$18.47B
Close$

Compare Alnylam Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Alnylam Pharmaceuticals IncAlnylam Pharmaceuticals Inc-41.90%200%11-4.6
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$153.64

Current Fair Value

0.5% downside

Overvalued by 0.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$18.47 Billion
Enterprise Value$17.05 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-3.52
Beta0.0
Outstanding Shares125,945,793
Avg 30 Day Volume788,569

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-41.95
PEG125.01
Price to Sales11.03
Price to Book Ratio-77.2
Enterprise Value to Revenue9.32
Enterprise Value to EBIT-60.41
Enterprise Value to Net Income-39
Total Debt to Enterprise0.06
Debt to Equity-4.63

Revenue Sources

No data

ESG Score

No data

About Alnylam Pharmaceuticals Inc

CEO: John Maraganore